Our Co-Founder Claire Jacob Featured on Mindz_Talks
Our co-founder, Claire Jacob, Professor of Neurobiology at Johannes Gutenberg University Mainz, was recently featured on Mindz_Talks, discussing how scientific discovery can evolve into entrepreneurial action.
In this episode, Claire shares insights into translating academic research into innovation, the journey from lab to startup, and why Mainz offers a unique environment for life science development. The conversation highlights the importance of connecting fundamental science with real-world application, a core principle behind both AdRegeneer and EpiGeneer.
Epigeneer GmbH established in Mainz
11.09.2025
_edited.png)
Epigeneer GmbH has been established in Mainz, Germany, as a subsidiary of AdRegeneer AG. The new company focuses on developing transdermal patch therapies for patients with Multiple Sclerosis (MS) and other neurodegenerative diseases.
​
Building on AdRegeneer’s pioneering epigenetic platform technology, Epigeneer aims to restore lost neurological functions by promoting myelin repair. The team is committed to translating cutting-edge science into practical therapies that improve patients’ quality of life.
​
The Mainz location provides an ideal environment for scientific collaboration, clinical development, and partnership opportunities across Europe.